Primary cell culture

Last updated
Primary cell culture
Intestinal organoid.PNG
Primary interstinal organoid culture
Identifiers
MeSH D061251
Anatomical terminology

Primary cell culture is the ex vivo culture of cells freshly obtained from a multicellular organism, as opposed to the culture of immortalized cell lines. In general, primary cell cultures are considered more representative of in vivo tissues than cell lines, and this is recognized legally in some countries such as the UK (Human Tissue Act 2004). [1] However, primary cells require adequate substrate and nutrient conditions to thrive and after a certain number of divisions they acquire a senescent phenotype, leading to irreversible cell cycle arrest. [2] The generation of cell lines stems from these two reasons. Primary cells can become immortalized either spontaneously (e.g. HeLa cells) or by genetic modification (e.g. HEK cells), at which point they become cell lines which can be subcultured indefinitely. [3]

Contents

Because of their requirements for viability, primary cell cultures did not become widespread until the 2000s. These cultures present several advantages over cell lines, including a better representation of the cellular heterogeneity of tissues, a more faithful transcriptomic and proteomic profile (especially when cultured in 3D) and more realistic functional responses, including drug responses. [4] [5] [6] In contrast, immortalized cell lines are known to become homogeneous through the natural selection of specific subpopulations, to undergo genetic drift and to acquire genetic aberrations. In many cases, cell lines have been misidentified, contaminated with other cells or infected with Mycoplasma , small intracellular bacteria that went undetected for decades. [4] [7]

When whole or partial tissues are isolated and maintained ex vivo, the procedure is termed primary tissue culture . More specific terms include organotypic culture, [8] tissue slices [9] and explants. [10]

Neuronal primary cell cultures are cells collected from the brain of an organism. For example they can be used when examining substances effect on cell viability, which can further on be potential treatments for brain deficits. [11]

Monolayer cultures

Monolayer cultures refer to cell cultures where cells are grown in a single, flat layer on the surface of a culture dish or substrate. In a monolayer culture, cells adhere to the substrate and spread out in a two-dimensional arrangement. This type of cell culture is commonly used in laboratory settings for various purposes, including research, drug testing, and biotechnology.[ citation needed ]

Key features of monolayer cultures include:

Monolayer cultures for personalized therapy

The endocrine cancer with the highest incidence is thyroid cancer (TC).[ citation needed ] Differentiated thyroid cells (DTC) that originate from follicular thyroid cells account for over 90% of total thyroid cells (TC). Papillary TC (PTC), follicular TC (FTC), and Hürthle cell TC are examples of DTC. One percent of TC is anaplastic TC (ATC), which accounts for 15–40% of TC deaths. [14]

Mortality is one of the biggest obstacles to current treatment techniques against aggressive DTC or ATC. These strategies are not entirely effective against these conditions. Recent years have seen advancements in our knowledge of the molecular and genetic underpinnings of TC development as well as the introduction of novel medications, such as tyrosine kinase inhibitors (TKIs), which target the oncogenic or signaling kinases linked to cellular proliferation. [14]

Preclinical models have made use of thyroid cell lines that were isolated from tumor cells and selected for their high rate of proliferation in vitro. As a result of their adaptation to in vitro growth circumstances, these cells actually lose the distinctive characteristics of the original tumor. Because of these factors, there are significant restrictions on the usage of these cell lines. More recently, monolayer cultures of human primary cells have been created, and their biological behavior has been studied. Furthermore, whereas human primary cell cultures may now be created from samples of fine-needle aspiration cytology from aggressive dedifferentiated DTC or ATC, primary TC cells were previously only obtained by surgical biopsies. Without the use of useless medications, testing several TKIs in vitro on individual patients can aid in the development of novel, individualized treatments. [14]

Limitations of monolayer culture and motivations:

Scientists are investigating novel models that can more accurately mimic the structure and function of human organs because to the limitations of monolayer culture settings. Protocol improvements in recent times have led to the creation of three-dimensional (3D) organ-like architectures known as "organoids," which are able to exhibit properties of their corresponding real organs, such as morphological features, functional activities, and individual responses to particular pathogens. [15]

Cell culture protocol

For in vitro investigations to be conducted correctly, the cell culture protocol for a particular cell line must be optimized. The best culture conditions for different cell lines can differ significantly due to the heterogeneity of germ cell malignancies. [16]

See also

References

  1. Geraghty RJ, Capes-Davis A, Davis JM, Downward J, Freshney RI, Knezevic I, et al. (September 2014). "Guidelines for the use of cell lines in biomedical research". British Journal of Cancer. 111 (6): 1021–1046. doi: 10.1038/bjc.2014.166 . PMC   4453835 . PMID   25117809.
  2. Campisi J, d'Adda di Fagagna F (September 2007). "Cellular senescence: when bad things happen to good cells". Nature Reviews. Molecular Cell Biology. 8 (9): 729–740. doi:10.1038/nrm2233. PMID   17667954. S2CID   15664931.
  3. Freshney RI, Freshney MG, eds. (1996). Culture of immortalized cells. New York: Wiley-Liss. ISBN   978-0-471-12134-3.
  4. 1 2 Gillet JP, Varma S, Gottesman MM (April 2013). "The clinical relevance of cancer cell lines". Journal of the National Cancer Institute. 105 (7): 452–458. doi: 10.1093/jnci/djt007 . PMC   3691946 . PMID   23434901.
  5. Cree IA, Glaysher S, Harvey AL (August 2010). "Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue". Current Opinion in Pharmacology. 10 (4): 375–379. doi:10.1016/j.coph.2010.05.001. PMID   20570561.
  6. Tiriac H, Belleau P, Engle DD, Plenker D, Deschênes A, Somerville TD, et al. (September 2018). "Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer". Cancer Discovery. 8 (9): 1112–1129. doi: 10.1158/2159-8290.CD-18-0349 . PMC   6125219 . PMID   29853643.
  7. American Type Culture Collection Standards Development Organization Workgroup ASN-0002 (June 2010). "Cell line misidentification: the beginning of the end". Nature Reviews. Cancer. 10 (6): 441–448. doi:10.1038/nrc2852. PMID   20448633. S2CID   1904739.{{cite journal}}: CS1 maint: numeric names: authors list (link)
  8. Vaira V, Fedele G, Pyne S, Fasoli E, Zadra G, Bailey D, et al. (May 2010). "Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors". Proceedings of the National Academy of Sciences of the United States of America. 107 (18): 8352–8356. Bibcode:2010PNAS..107.8352V. doi: 10.1073/pnas.0907676107 . PMC   2889536 . PMID   20404174.
  9. Meijer TG, Naipal KA, Jager A, van Gent DC (June 2017). "Ex vivo tumor culture systems for functional drug testing and therapy response prediction". Future Science OA. 3 (2): FSO190. doi: 10.4155/fsoa-2017-0003 . PMC   5481868 . PMID   28670477.
  10. Carranza-Torres IE, Guzmán-Delgado NE, Coronado-Martínez C, Bañuelos-García JI, Viveros-Valdez E, Morán-Martínez J, Carranza-Rosales P (2015). "Organotypic culture of breast tumor explants as a multicellular system for the screening of natural compounds with antineoplastic potential". BioMed Research International. 2015: 618021. doi: 10.1155/2015/618021 . PMC   4449881 . PMID   26075250.
  11. Stam F, Florén Lind S, Schroff A, Zelleroth S, Nylander E, Gising J, et al. (October 2022). "Hydrogen Peroxide Induced Toxicity Is Reversed by the Macrocyclic IRAP-Inhibitor HA08 in Primary Hippocampal Cell Cultures". Current Issues in Molecular Biology. 44 (10): 5000–5012. doi: 10.3390/cimb44100340 . PMC   9601255 . PMID   36286055.
  12. 1 2 3 4 Harris, Andrew R.; Peter, Loic; Bellis, Julien; Baum, Buzz; Kabla, Alexandre J.; Charras, Guillaume T. (2012-10-09). "Characterizing the mechanics of cultured cell monolayers". Proceedings of the National Academy of Sciences. 109 (41): 16449–16454. Bibcode:2012PNAS..10916449H. doi: 10.1073/pnas.1213301109 . ISSN   0027-8424. PMC   3478631 . PMID   22991459.
  13. 1 2 3 Majhy, B.; Priyadarshini, P.; Sen, A. K. (2021). "Effect of surface energy and roughness on cell adhesion and growth – facile surface modification for enhanced cell culture". RSC Advances. 11 (25): 15467–15476. Bibcode:2021RSCAd..1115467M. doi:10.1039/D1RA02402G. ISSN   2046-2069. PMC   8698786 . PMID   35424027.
  14. 1 2 3 Fallahi, Poupak; Ferrari, Silvia Martina; Elia, Giusy; Ragusa, Francesca; Patrizio, Armando; Paparo, Sabrina Rosaria; Marone, Gianni; Galdiero, Maria Rosaria; Guglielmi, Giovanni; Foddis, Rudy; Cristaudo, Alfonso; Antonelli, Alessandro (February 2022). "Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin". Seminars in Cancer Biology. 79: 203–216. doi:10.1016/j.semcancer.2020.06.013. hdl: 11568/1051741 . PMID   32569821.
  15. Heydari, Zahra; Moeinvaziri, Farideh; Agarwal, Tarun; Pooyan, Paria; Shpichka, Anastasia; Maiti, Tapas K.; Timashev, Peter; Baharvand, Hossein; Vosough, Massoud (December 2021). "Organoids: a novel modality in disease modeling". Bio-Design and Manufacturing. 4 (4): 689–716. doi:10.1007/s42242-021-00150-7. ISSN   2096-5524. PMC   8349706 . PMID   34395032.
  16. Lafin, John T.; Amatruda, James F.; Bagrodia, Aditya (2021), Bagrodia, Aditya; Amatruda, James F. (eds.), "Germ Cell Tumor Cell Culture Techniques", Testicular Germ Cell Tumors, vol. 2195, New York, NY: Springer US, pp. 65–76, doi:10.1007/978-1-0716-0860-9_5, ISBN   978-1-0716-0859-3, PMID   32852757 , retrieved 2024-01-03